{"transactions":[{"id":1197070,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-03-19T15:03:42.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":1026228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 17, 2025 (the Grant Date) John Simard was granted nonstatutory stock options under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock at an exercise price equal to the closing price of the Company's common stock, as reported by the Nasdaq Stock Market, on the Grant Date. The options vested immediately on the Grant Date."}],"balance_after":1896609,"derivative":{"exercise_price":3.52,"exercise_date":"2025-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":1026228},"source":{"system":"sec-edgar","filing":"0000950170-25-041946","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000095017025041946/ownership.xml","form_type":"4"}},{"id":1284789,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Loan Agreement","published_at":"2025-02-04T16:53:27.000Z","date":"2025-01-31","kind":"other","planned":false,"acquired":false,"shares":2470355,"price":10000000,"value":24703550000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 31, 2025, the Convertible Loan Agreement (the \"Loan\") dated as of January 3, 2024 between XBiotech Inc. and John Simard, the Company's Founder, President, Chief Executive Officer, and Chairman, was terminated upon full repayment of the Loan by the Company. As a result, all conversion rights to XBiotech stock associated with the Loan were extinguished."}],"balance_after":870381,"derivative":{"exercise_price":4.048,"exercise_date":"2024-01-03","expiration_date":"2029-01-03","underlying":"Common Shares or Preferred Shares","underlying_shares":2470335},"source":{"system":"sec-edgar","filing":"0000950170-25-013647","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000095017025013647/ownership.xml","form_type":"4"}},{"id":1685474,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Convertible Loan Agreement","published_at":"2024-01-05T10:48:54.000Z","date":"2024-01-03","kind":"purchase","planned":false,"acquired":true,"shares":2470355,"price":10000000,"value":24703550000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 3, 2024, XBiotech Inc. (\"XBiotech\" or the \"Company\") entered into a Convertible Loan Agreement (the \"Loan\") with John Simard, the Company's Founder, President, Chief Executive Officer and Chairman. The Loan provides $10 million in immediate funding for the construction of a new, state-of-the-art research and development facility at 5217 Winnebago Lane in Austin, Texas. The Loan is secured by the real estate and cash holdings of the Company, with interest to accrue at a simple rate equal to eight percent per year and interest-only payments to be made at six - month intervals after the Loan is funded. At Mr. Simard's election, the balance may be converted to XBiotech stock at any time the Loan balance is outstanding at a fixed conversion price equal to the average Nasdaq Official Closing Price of the common stock (as reflected on Nasdaq.com) for the five trading days immediately preceding the signing of this Agreement, which is $4.048 per share. Continued in Remarks."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"As of the filing date of this Form 4, Mr. Simard could obtain up to 2,470,355 XBiotech common or preferred shares by converting the full $10,000,000 Loan balance at the conversion price of $4.048 per share. The total number of shares exercisable under the Loan could fluctuate based on Mr. Simard' cumulative stock ownership and the total number of XBiotech shares outstanding."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This figure is derived by adding the 2,470,355 shares that Mr. Simard could obtain by converting the Loan balance as of the filing date of this Form 4 to the 1,370,381 stock options Mr. Simard holds as previously disclosed in XBiotech's April 28, 2023 Schedule 14A.  As stated in footnote 2 above, the total number of shares exercisable under the Loan could fluctuate based on Mr. Simard' cumulative stock ownership and the total number of XBiotech shares outstanding."}],"balance_after":3840736,"derivative":{"exercise_price":4.048,"exercise_date":"2024-01-03","expiration_date":"2029-01-03","underlying":"Common Shares or Preferred Shares","underlying_shares":2470355},"source":{"system":"sec-edgar","filing":"0000950170-24-002316","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000095017024002316/ownership.xml","form_type":"4"}},{"id":2394497,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-15T16:05:31.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":33000,"price":13.0683,"value":431253.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3823166,"source":{"system":"sec-edgar","filing":"0001209191-22-009745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919122009745/doc4.xml","form_type":"4"}},{"id":2394496,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-15T16:05:31.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":17000,"price":13.3218,"value":226470.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3856166,"source":{"system":"sec-edgar","filing":"0001209191-22-009745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919122009745/doc4.xml","form_type":"4"}},{"id":2541662,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-15T12:26:50.000Z","date":"2021-10-14","kind":"sale","acquired":false,"shares":21125,"price":12.9005,"value":272523.0625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3873166,"source":{"system":"sec-edgar","filing":"0001209191-21-060523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121060523/doc4.xml","form_type":"4"}},{"id":2541661,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-15T12:26:50.000Z","date":"2021-10-13","kind":"sale","acquired":false,"shares":10875,"price":12.83,"value":139526.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3962452,"source":{"system":"sec-edgar","filing":"0001209191-21-060523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121060523/doc4.xml","form_type":"4"}},{"id":2541660,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-15T12:26:50.000Z","date":"2021-10-12","kind":"sale","acquired":false,"shares":18000,"price":12.7744,"value":229939.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3973166,"source":{"system":"sec-edgar","filing":"0001209191-21-060523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121060523/doc4.xml","form_type":"4"}},{"id":2541659,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-15T12:26:50.000Z","date":"2021-10-07","kind":"sale","acquired":false,"shares":39286,"price":12.45,"value":489110.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3923166,"source":{"system":"sec-edgar","filing":"0001209191-21-060523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121060523/doc4.xml","form_type":"4"}},{"id":2547164,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-06T17:48:48.000Z","date":"2021-10-06","kind":"sale","acquired":false,"shares":10714,"price":12.5312,"value":134259.2768,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3962452,"source":{"system":"sec-edgar","filing":"0001209191-21-059849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121059849/doc4.xml","form_type":"4"}},{"id":2547163,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-06T17:48:48.000Z","date":"2021-10-05","kind":"sale","acquired":false,"shares":14218,"price":12.6641,"value":180058.1738,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3973166,"source":{"system":"sec-edgar","filing":"0001209191-21-059849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121059849/doc4.xml","form_type":"4"}},{"id":2547162,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-06T17:48:48.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":23681,"price":13.0849,"value":309863.5169,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":3987384,"source":{"system":"sec-edgar","filing":"0001209191-21-059849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121059849/doc4.xml","form_type":"4"}},{"id":2554394,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-01T16:39:14.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":19684,"price":13.2335,"value":260488.214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4011065,"source":{"system":"sec-edgar","filing":"0001209191-21-058475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121058475/doc4.xml","form_type":"4"}},{"id":2554393,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-01T16:39:14.000Z","date":"2021-09-30","kind":"sale","acquired":false,"shares":18558,"price":13.0652,"value":242463.9816,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4030749,"source":{"system":"sec-edgar","filing":"0001209191-21-058475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121058475/doc4.xml","form_type":"4"}},{"id":2554392,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-01T16:39:14.000Z","date":"2021-09-29","kind":"sale","acquired":false,"shares":16396,"price":13.4058,"value":219801.4968,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4049307,"source":{"system":"sec-edgar","filing":"0001209191-21-058475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121058475/doc4.xml","form_type":"4"}},{"id":2554391,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-01T16:39:14.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":6263,"price":14.2685,"value":89363.6155,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4065703,"source":{"system":"sec-edgar","filing":"0001209191-21-058475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121058475/doc4.xml","form_type":"4"}},{"id":2557700,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-28T10:59:07.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":29890,"price":14.814,"value":442790.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4071966,"source":{"system":"sec-edgar","filing":"0001209191-21-057877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121057877/doc4.xml","form_type":"4"}},{"id":2557699,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-28T10:59:07.000Z","date":"2021-09-24","kind":"sale","acquired":false,"shares":11418,"price":14.4867,"value":165409.1406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4101856,"source":{"system":"sec-edgar","filing":"0001209191-21-057877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121057877/doc4.xml","form_type":"4"}},{"id":2557698,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-28T10:59:07.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":9892,"price":14.6805,"value":145219.506,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4113274,"source":{"system":"sec-edgar","filing":"0001209191-21-057877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121057877/doc4.xml","form_type":"4"}},{"id":2561991,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-22T18:12:33.000Z","date":"2021-09-22","kind":"sale","acquired":false,"shares":19669,"price":15.1384,"value":297757.1896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4123166,"source":{"system":"sec-edgar","filing":"0001209191-21-057295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121057295/doc4.xml","form_type":"4"}},{"id":2561990,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-22T18:12:33.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":16860,"price":15.238,"value":256912.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4142835,"source":{"system":"sec-edgar","filing":"0001209191-21-057295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121057295/doc4.xml","form_type":"4"}},{"id":2561989,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-22T18:12:33.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":13471,"price":15.063,"value":202913.673,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4159695,"source":{"system":"sec-edgar","filing":"0001209191-21-057295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121057295/doc4.xml","form_type":"4"}},{"id":2630555,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-19T14:27:18.000Z","date":"2021-07-14","kind":"sale","acquired":false,"shares":50000,"price":18.147,"value":907350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4173166,"source":{"system":"sec-edgar","filing":"0001209191-21-047105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121047105/doc4.xml","form_type":"4"}},{"id":2738478,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2021-04-27T17:33:17.000Z","date":"2020-08-27","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":18.25,"exercise_date":"2021-02-27","expiration_date":"2030-08-27","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001209191-21-028625","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121028625/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-01"}},{"id":2776269,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options","published_at":"2021-03-22T14:20:11.000Z","date":"2021-03-22","kind":"exercise","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.5,"exercise_date":"2012-04-12","expiration_date":"2021-04-12","underlying":"Common Stocks","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-21-022278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121022278/doc4.xml","form_type":"4"}},{"id":2776268,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2021-03-22T14:20:11.000Z","date":"2021-03-22","kind":"exercise","acquired":true,"shares":500000,"price":7.5,"value":3750000.0,"ownership":{"direct":true},"balance_after":4223166,"source":{"system":"sec-edgar","filing":"0001209191-21-022278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121022278/doc4.xml","form_type":"4"}},{"id":2888631,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2021-02-01T11:01:34.000Z","date":"2021-01-28","kind":"other","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":500000,"derivative":{"exercise_price":11.12,"exercise_date":"2020-12-06","expiration_date":"2029-12-06","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-21-006384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121006384/doc4.xml","form_type":"4"}},{"id":2888630,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2021-02-01T11:01:34.000Z","date":"2021-01-28","kind":"other","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":150000,"derivative":{"exercise_price":7.45,"exercise_date":"2020-12-27","expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-21-006384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121006384/doc4.xml","form_type":"4"}},{"id":2888629,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2021-02-01T11:01:34.000Z","date":"2021-01-28","kind":"other","acquired":false,"shares":89260,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":110740,"derivative":{"exercise_price":4.44,"exercise_date":"2020-06-19","expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":89260},"source":{"system":"sec-edgar","filing":"0001209191-21-006384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121006384/doc4.xml","form_type":"4"}},{"id":2888628,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2021-02-01T11:01:34.000Z","date":"2021-01-28","kind":"other","acquired":false,"shares":13484,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61516,"derivative":{"exercise_price":4.24,"exercise_date":"2020-06-19","expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":13484},"source":{"system":"sec-edgar","filing":"0001209191-21-006384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121006384/doc4.xml","form_type":"4"}},{"id":2888627,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2021-02-01T11:01:34.000Z","date":"2021-01-28","kind":"other","acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48125,"derivative":{"exercise_price":9.45,"exercise_date":"2019-03-31","expiration_date":"2026-03-31","underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001209191-21-006384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919121006384/doc4.xml","form_type":"4"}},{"id":3025987,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-21T17:07:49.000Z","date":"2020-09-18","kind":"other","acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares transferred pursuant to obligation"}],"balance_after":3723166,"source":{"system":"sec-edgar","filing":"0001209191-20-051306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919120051306/doc4.xml","form_type":"4"}},{"id":3042618,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2020-09-01T16:05:34.000Z","date":"2020-08-27","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":18.25,"exercise_date":"2021-02-27","expiration_date":"2030-08-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-048900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919120048900/doc4.xml","form_type":"4"}},{"id":3200758,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-19T13:29:18.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":2103894,"price":30,"value":63116820.0,"ownership":{"direct":true},"balance_after":4223166,"source":{"system":"sec-edgar","filing":"0001209191-20-020220","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919120020220/doc4a.xml","form_type":"4/A","original_submission_date":"2020-02-13"}},{"id":3273937,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-13T16:48:11.000Z","date":"2020-02-12","kind":"disposition_to_issuer","acquired":false,"shares":2016466,"price":30,"value":60493980.0,"ownership":{"direct":true},"balance_after":4310594,"source":{"system":"sec-edgar","filing":"0001209191-20-009272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919120009272/doc4.xml","form_type":"4"}},{"id":3345306,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2019-12-11T15:52:34.000Z","date":"2019-12-06","kind":"exercise","acquired":true,"shares":1000000,"price":11.12,"value":11120000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On December 6, 2019 (the Grant Date) John Simard was granted nonstatutory stock options under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock at an exercise price equal to the closing price of the Company's common stock, as reported by the Nasdaq Stock Market, on the Grant Date. The options will vest in two equal installments on the six-month anniversary and the first anniversary of the Grant Date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On December 6, 2019 (the Grant Date) John Simard was granted nonstatutory stock options under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock at an exercise price equal to the closing price of the Company's common stock, as reported by the Nasdaq Stock Market, on the Grant Date. The options will vest in two equal installments on the six-month anniversary and the first anniversary of the Grant Date."}],"balance_after":2625000,"derivative":{"exercise_price":11.12,"exercise_date":"2020-06-11","expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001209191-19-060015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919119060015/doc4.xml","form_type":"4"}},{"id":3476045,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2019-06-28T17:24:38.000Z","date":"2019-06-27","kind":"exercise","acquired":true,"shares":300000,"price":7.45,"value":2235000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 27, 2019 (the Grant Date) John Simard was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The options vest in three equal annual installments commencing as of the first anniversary of the Grant Date with an expiry of ten years from the Grant Date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 27, 2019 (the Grant Date) John Simard was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The options vest in three equal annual installments commencing as of the first anniversary of the Grant Date with an expiry of ten years from the Grant Date."}],"balance_after":300000,"derivative":{"exercise_price":7.45,"exercise_date":"2020-06-27","expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-19-039527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919119039527/doc4.xml","form_type":"4"}},{"id":3723341,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2018-12-20T11:00:31.000Z","date":"2018-12-19","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.5,"exercise_date":"2009-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-18-063616","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919118063616/doc4.xml","form_type":"4"}},{"id":3723340,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-12-20T11:00:31.000Z","date":"2018-12-19","kind":"exercise","acquired":true,"shares":50000,"price":2.5,"value":125000.0,"ownership":{"direct":true},"balance_after":6327060,"source":{"system":"sec-edgar","filing":"0001209191-18-063616","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919118063616/doc4.xml","form_type":"4"}},{"id":3791953,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2018-10-12T15:00:57.000Z","date":"2018-07-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Spouse"},"balance_after":15000,"derivative":{"exercise_price":4.26,"exercise_date":"2019-05-29","expiration_date":"2028-05-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-054878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919118054878/doc4.xml","form_type":"4"}},{"id":3886141,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2018-06-21T15:13:26.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":4.44,"exercise_date":"2019-06-19","expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-038901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919118038901/doc4.xml","form_type":"4"}},{"id":4273538,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2017-06-23T14:54:21.000Z","date":"2017-06-19","kind":"exercise","acquired":true,"shares":75000,"price":4.24,"value":318000.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":4.24,"exercise_date":"2018-06-19","expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-041618","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919117041618/doc4a.xml","form_type":"4/A","original_submission_date":"2017-06-23"}},{"id":4273537,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2017-06-23T14:17:10.000Z","date":"2017-06-19","kind":"exercise","acquired":true,"shares":75000,"price":4.24,"value":318000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On September 14, 2016 (the Grant Date) Fabrizio Bonanni was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purcahse shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market, with an expiry of ten years from the Grant Date. Half of the Options vest on December 20, 2016 and another half of the Options vest on June 20, 2017."}],"balance_after":75000,"derivative":{"exercise_price":4.24,"exercise_date":"2018-06-19","expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-17-041609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919117041609/doc4.xml","form_type":"4"}},{"id":4304883,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2017-05-25T17:12:48.000Z","date":"2017-05-24","kind":"exercise","acquired":false,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Options granted on June 15, 2007 with a strike price of $1.25 CAD, which was converted to $0.9317 USD using an exchange rate of 0.7454."}],"balance_after":0,"derivative":{"exercise_price":0.9317,"exercise_date":"2008-06-15","expiration_date":"2017-06-15","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001209191-17-035497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919117035497/doc4.xml","form_type":"4"}},{"id":4304882,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-25T17:12:48.000Z","date":"2017-05-24","kind":"tax_withholding","acquired":false,"shares":116207,"price":8.17,"value":949411.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Due to the options expiring on June 15, 2017, Mr. Simard agreed to exercise these options through the \"net exercise\" method on May 24, 2017. Mr. Simard received 123,793 shares of common stock on a net exercise to purchase 240,000 shares of common stock. Mr. Simard forfeited 116,207 shares of common stock underlying the option in payment of the exercise price and associated taxes, using the closing stock price on May 24, 2017 of $8.17."}],"balance_after":6277060,"source":{"system":"sec-edgar","filing":"0001209191-17-035497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919117035497/doc4.xml","form_type":"4"}},{"id":4304881,"issuer":{"id":7044,"kind":"organization","name":"XBiotech Inc."},"owners":[{"id":81757,"kind":"person","name":"SIMARD JOHN","position":1,"cik":"0001639078","reported_name":"SIMARD JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-25T17:12:48.000Z","date":"2017-05-24","kind":"exercise","acquired":true,"shares":240000,"price":0.9317,"value":223608.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Options granted on June 15, 2007 with a strike price of $1.25 CAD, which was converted to $0.9317 USD using an exchange rate of 0.7454."}],"balance_after":6393267,"source":{"system":"sec-edgar","filing":"0001209191-17-035497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639078/000120919117035497/doc4.xml","form_type":"4"}}]}